What does MEDISCH CENTRUM GENK do?

MEDISCH CENTRUM GENK is a specialist medical practice in Genk. Private Limited, started on 21 August 1987, 2 establishments.

What is the address of MEDISCH CENTRUM GENK?

The registered office of MEDISCH CENTRUM GENK is located at Weg naar As 123, 3600 Genk.

Is MEDISCH CENTRUM GENK still active?

Yes. According to the CBE (29 October 2026) MEDISCH CENTRUM GENK is active, legal situation “Normale toestand”, started on 21 August 1987.

Is MEDISCH CENTRUM GENK registered on Peppol?

Yes, MEDISCH CENTRUM GENK is registered on the Peppol network with ID 0208:0431775110.

What is the enterprise number of MEDISCH CENTRUM GENK?

The enterprise number of MEDISCH CENTRUM GENK is BE0431775110.

When was MEDISCH CENTRUM GENK founded?

MEDISCH CENTRUM GENK was founded on 21 August 1987.

Who are the directors of MEDISCH CENTRUM GENK?

According to the 2025 annual accounts, the directors of MEDISCH CENTRUM GENK are: Dr. Heleen Cypers, Reumatologie BV, Dr. Thevissen Kristof BV, Dr. Joris Heyligen, Reumatologie BV, Medical Experts BV, Dr. Marc Piessens BV, Drs. Remans Reumatologie BV, Dokters Gevers BV, Dokter Jorissen BV.

Is MEDISCH CENTRUM GENK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 August 1987; 5 annual accounts filed, latest fiscal year 2025; 14 directors known from the annual account; 2 establishments in the CBE.

How much profit did MEDISCH CENTRUM GENK make in 2025?

MEDISCH CENTRUM GENK recorded a loss after taxes of € 57,094 in financial year 2025.

What is the revenue of MEDISCH CENTRUM GENK?

As a small company, MEDISCH CENTRUM GENK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 859,250.

How much does an employee at MEDISCH CENTRUM GENK earn?

The average wage cost per full-time employee at MEDISCH CENTRUM GENK was € 67,200 in 2025: staff costs of € 839,798 for 12.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does MEDISCH CENTRUM GENK have?

According to the 2025 annual accounts, MEDISCH CENTRUM GENK has 12.5 full-time equivalents (FTE).

MEDISCH CENTRUM GENK (Private Limited) - Genk

Dossier MEDISCH CENTRUM GENK, printed on 29 October 2026 from databakkes.be/en/0431775110/medisch-centrum-genk. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDISCH CENTRUM GENK from Genk, company number BE0431775110, closed financial year 2025 with a result of € -57,094 after tax. For that financial year MEDISCH CENTRUM GENK recorded a gross margin of € 859,250 and equity of € 70,679. Compared with financial year 2024, the result moved from € 26,305 to € -57,094. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.

What it is worth Healthy

€ 70,679

▼ 45% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -57,094

▼ still € 26,305 profit in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 184,805

▼ 30% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -46,720.

People and assets in 2025

Full-time equivalents

12.5

▲ 0.5 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 839,798

▲ 6% vs 2024

€ 67,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 274,367

▲ € 213,338 vs 2024

Of which on lease € 245,006.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 229,683

€ 33,619 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 22,446

▼ 7% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 150,240

▲ 9% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 760,002 Gross margin 2022: € 760,002 First fiscal year in the series	€ 799,761 Gross margin 2023: € 799,761 ▲ 5% vs 2022 (€ 760,002) Favourable step	€ 905,995 Gross margin 2024: € 905,995 ▲ 13% vs 2023 (€ 799,761) Favourable step	€ 859,250 Gross margin 2025: € 859,250 ▼ 5% vs 2024 (€ 905,995) Unfavourable step	▼ 5%
Profit after taxes	€ 43,993 Profit after taxes 2022: € 43,993 First fiscal year in the series	€ 19,642 Profit after taxes 2023: € 19,642 ▼ 55% vs 2022 (€ 43,993) Unfavourable step	€ 26,305 Profit after taxes 2024: € 26,305 ▲ 34% vs 2023 (€ 19,642) Favourable step	€ -57,094 Profit after taxes 2025: € -57,094 ▼ € 83,399 vs 2024 (€ 26,305) Unfavourable step	▼ € 83,399
Equity	€ 81,826 Equity 2022: € 81,826 First fiscal year in the series	€ 101,469 Equity 2023: € 101,469 ▲ 24% vs 2022 (€ 81,826) Favourable step	€ 127,773 Equity 2024: € 127,773 ▲ 26% vs 2023 (€ 101,469) Favourable step	€ 70,679 Equity 2025: € 70,679 ▼ 45% vs 2024 (€ 127,773) Unfavourable step	▼ 45%
Total debts	€ 816,508 Total debts 2022: € 816,508 First fiscal year in the series	€ 600,963 Total debts 2023: € 600,963 ▼ 26% vs 2022 (€ 816,508) Favourable step	€ 664,050 Total debts 2024: € 664,050 ▲ 10% vs 2023 (€ 600,963) Unfavourable step	€ 934,492 Total debts 2025: € 934,492 ▲ 41% vs 2024 (€ 664,050) Unfavourable step	▲ 41%
Cash	€ 340,139 Cash 2022: € 340,139 First fiscal year in the series	€ 200,974 Cash 2023: € 200,974 ▼ 41% vs 2022 (€ 340,139) Unfavourable step	€ 262,796 Cash 2024: € 262,796 ▲ 31% vs 2023 (€ 200,974) Favourable step	€ 184,805 Cash 2025: € 184,805 ▼ 30% vs 2024 (€ 262,796) Unfavourable step	▼ 30%
Land & buildings	-	-	€ 28,507 Land & buildings 2024: € 28,507 First fiscal year in the series	€ 27,037 Land & buildings 2025: € 27,037 ▼ 5% vs 2024 (€ 28,507) Unchanged	▼ 5%
Retained profit	€ -35,572 Retained profit 2022: € -35,572 First fiscal year in the series	€ -15,930 Retained profit 2023: € -15,930 ▲ € 19,642 vs 2022 (€ -35,572) Favourable step	€ 10,375 Retained profit 2024: € 10,375 ▲ € 26,305 vs 2023 (€ -15,930) Favourable step	€ -46,720 Retained profit 2025: € -46,720 ▼ € 57,094 vs 2024 (€ 10,375) Unfavourable step	▼ € 57,094
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 229,683 Bank debt 2025: € 229,683 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 898,334 Balance sheet total 2022: € 898,334 First fiscal year in the series	€ 702,432 Balance sheet total 2023: € 702,432 ▼ 22% vs 2022 (€ 898,334) Unchanged	€ 791,824 Balance sheet total 2024: € 791,824 ▲ 13% vs 2023 (€ 702,432) Unchanged	€ 1,005,171 Balance sheet total 2025: € 1,005,171 ▲ 27% vs 2024 (€ 791,824) Unchanged	▲ 27%
Employees (FTE)	10.1 Employees (FTE) 2022: 10.1 First fiscal year in the series	10.7 Employees (FTE) 2023: 10.7 ▲ 0.6 vs 2022 (10.1) Unchanged	12 Employees (FTE) 2024: 12 ▲ 1.3 vs 2023 (10.7) Unchanged	12.5 Employees (FTE) 2025: 12.5 ▲ 0.5 vs 2024 (12) Unchanged	▲ 0.5

Key figures of MEDISCH CENTRUM GENK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDISCH CENTRUM GENK?

What happened at MEDISCH CENTRUM GENK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Dokters Gevers BV stepped down as director. NBB
2029 Boelhouwers Reumatologie BV stepped down as director. NBB
2029 Dr. Joris Heyligen, Reumatologie BV stepped down as director. NBB
2028 Dr. Heleen Cypers, Reumatologie BV stepped down as director. NBB
2028 Dr. Van den Bossche Bert, Reumatoloog BV stepped down as director. NBB
2028 Dr. I. Gofita Reumatoloog BV stepped down as director. NBB
2027 Dr. Marc Piessens BV stepped down as director. NBB
2027 Dr. PH. De Vusser BV stepped down as director. NBB

In short

From € 43,993 profit in 2022 to € 57,094 loss in 2025.

Paid € 17,117 in corporate taxes since 2022.

Best year ever: 2022, with € 43,993 profit.

On average € 68,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

DRS. REMANS REUMATOLOGIE 79%

The stake of DRS. REMANS REUMATOLOGIE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

MEDISCH CENTRUM GENK

The shares are held by DRS. REMANS REUMATOLOGIE (79%).

Directors

According to the 2025 annual accounts

Dr. Heleen Cypers, Reumatologie BV

Director · represented by Heleen Cypers

since 2022 · until 2028

Dr. Thevissen Kristof BV

Director · represented by Kristof Thevissen

since 2020 · until 2026

Dr. Joris Heyligen, Reumatologie BV

Director · represented by Joris Heyligen

since 2023 · until 2029

Medical Experts BV

Director · represented by Spyridon Kefalas

since 2020 · until 2026

Dr. Marc Piessens BV

Director · represented by Marc Piessens

since 2021 · until 2027

Drs. Remans Reumatologie BV

Director · represented by Philip Remans

since 2020 · until 2026

Dokters Gevers BV

Director · represented by Anna-Maria Gevers

since 2023 · until 2029

Dokter Jorissen BV

Director · represented by Patrick Jorissen

since 2020 · until 2026

Dr. Van den Bossche Bert, Reumatoloog BV

Director · represented by Bert Van Den Bossche

since 2022 · until 2028

Dokter Bambynek BV

Director · represented by Christoph Bambynek

since 2020 · until 2026

Dr. PH. De Vusser BV

Director · represented by Philip De Vusser

since 2021 · until 2027

Jan Remans

Director

since 2020 · until 2026

Dr. I. Gofita Reumatoloog BV

Director · represented by Ioana Gofita

since 2022 · until 2028

Boelhouwers Reumatologie BV

Director · represented by Fleur Boelhouwers

since 2023 · until 2029

Shareholders

DRS. REMANS REUMATOLOGIE

79%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Weg naar As 123

3600 Genk

2.348.715.834

Weg naar As 100

3600 Genk

Active since 1 October 2023

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.

All companies at this address →

VERE

€ 457,762 gross margin · 2025

MAATSCHAP MARJAN

GLOCOLEARNING

€ 39,407 gross margin · 2025

DRS. REMANS REUMATOLOGIE same network

€ 463,548 gross margin · 2025

Boelhouwers Reumatologie same network

€ 113,047 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0431.775.110

VAT number

BE 0431.775.110

Registered office

Weg naar As 123, 3600 Genk

Names & denominations

MEDISCH CENTRUM GENK · M.C.G.

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

21 August 1987

Peppol

Active · Active since 9 Dec 2025

Activities · NACE

Activiteiten van medisch specialisten

Medische praktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

MEDISCH CENTRUM GENK

Financials

What happened to MEDISCH CENTRUM GENK?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions